购物车
全部删除
您的购物车当前为空
Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 是一种抗体-药物偶联物 (ADC),由人源性抗SLC34A2抗体Lifastuzumab与连接子Mc-VC-PAB和拓扑异构酶I抑制剂SN38缀合而成。其毒性分子和连接部分为Mc-VC-PAB-SN38。Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 可用于癌症研究。
Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 是一种抗体-药物偶联物 (ADC),由人源性抗SLC34A2抗体Lifastuzumab与连接子Mc-VC-PAB和拓扑异构酶I抑制剂SN38缀合而成。其毒性分子和连接部分为Mc-VC-PAB-SN38。Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 可用于癌症研究。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 12,000 | 待询 | |
| 5 mg | 待询 | 待询 |
Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 相关产品
| 产品描述 | Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) composed of the human-derived anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab, linked with the Mc-VC-PAB connector and the topoisomeraseI inhibitor SN38. The ADC's cytotoxic component and linker are Mc-VC-PAB-SN38. This compound is utilized in cancer research. |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容